Cardiac effects of benzodiazepine receptor agonists and antagonists in the isolated rat heart: A comparative study

Life Sciences

Volumn 63, Issue 16, 1998, Pages 1439-1456

  Zeegers, Arie ^a   Van Wilgenburg, Henk ^a   Leeuwin, Remy S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Benzodiazepine antagonists; Benzodiazepines; Coronary flow; Inotropy; Langendorff heart; Zolpidem

Indexed keywords

BENZODIAZEPINE RECEPTOR; CLONAZEPAM; FLUMAZENIL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; ZOLPIDEM;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; HEART CONTRACTION; INOTROPISM; NONHUMAN; RAT;

ANIMALS; BENZODIAZEPINES; CARDIAC OUTPUT; CLONAZEPAM; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUMAZENIL; HEART; ISOQUINOLINES; MYOCARDIAL CONTRACTION; PERFUSION; PYRIDINES; RATS; RECEPTORS, GABA-A;

EID: 0032508673     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00411-1     Document Type: Article

References (38)

1. 1. TH.W. RALL, In: Goodman Gilman, A., T.W. Rall, A.S. Nies and P. Taylor (Eds.). The Pharmacological Basis of Therapeutics, New York, Pergamon Press, 8th ed. 345-382 (1990).
2. 2. R.M. ABEL, R.L. REIS, R.N. STAROSCIK, Br. J. Pharmacol. 38 620-631 (1970).
3. 3. H. IKRAM, A.P. RUBIN, R.F. JEWKES, Br. Heart J. 35 626-630 (1973).
4. 4. H.B. DANIELL, Europ. J. Pharmacol. 32 58-65 (1975).
5. 5. J.R. CASTILLO-FERRANDO, E. PEREZ OJEDAG, J.L ENCINA, J.S. SERRANO, J. Pharm. Pharmacol. 8 828-829 (1985).
6. 6. S.C. HASKINS, T.B. FARVER, J.D. PATZ, Amer. J. Vet. Res. 47 795-798 (1986).
7. 7. K. AKAHANE, Y. FURUKAWA, Y. OGIWARA, M. HANIUDA, M. TAKEDA, S. CHIBA, Arch. Int. Pharmacodyn. Thér. 290 173-184 (1987).
8. 8. R.S. LEEUWIN, A. ZEEGERS, H. VAN WILGENBURG, Arch. Int. Pharmacodyn. Thér. 326 5-12 (1993).
9. 9. I.L. GRUPP, J.F. FRENCH, M.A. MATLIB, Europ. J. Pharmacol. 143 143-147 (1987).
10. 10. R.S. LEEUWIN, A. ZEEGERS, J. VAN HAMME, H. VAN WILGENBURG, Life Sci. 61 1631-1642 (1997).
11. 11. L.P. DAVIES, V. HUSTON, Europ. J. Pharmacol. 73 209-211 (1981).
12. 12. T. TANIGUCHI, J.K.T. WANG, S. SPECTOR, Biochem. Pharmacol. 31 589 (1983).
13. 13. A. VERMA, S.H. SNYDER, Ann. Rev. Pharmacol. Toxicol. 29 307-322 (1989).
14. 14. A.L. PAROLA, H.I. YAMAMURA, H.E. LAIRD, Life Sci. 52 1329-1342 (1993) .
15. 15. V.L.R. RAO, R. AUDET, G. THERRIEN, R.F. BUTTERWORTH, Digestive Diseases and Sciences 39 1055-1066 (1994).
16. 16. P. CHARBONNEAU, A. SYROTA, CHR. CROUZEL, J-M. VALOIS, CHR. PRENANT, M. CROUZEL, Circulation 73 476-483 (1986).
17. 17. R. FARGES, E. JOSEPH-LIAUZUN, D. SHIRE, D. CAPUT, G. LE FUR, G. LOISON, F. PASCUAL, FEBS 335 305-308 (1993).
18. 18. W. HUNKELER, H. MÖHLER, L. PIERI, P. POLK, E. P. BONETTI, R. CUMIN, R. SCHAFFNER, W.E. HAEFELY, Nature 90 514-516 (1981).
19. 19. G. LE FUR, M.L. PERRIER, H. VAUCHER, F. IMBAULT, A. FLAMIER, J. BENAVIDES, A. UZAN, C. RENAULT, M.C. DUBROEUCQ, C. GUEREMY, Life Sci. 32 1839-1847 (1983).
20. 20. H. MÖHLER, J.G. RICHARDS, Europ. J. Anaesthesiol. suppl. 2 15-24 (1988).
21. 21. J.G. WHITWAM, R. AMREIN, Acta Anaesthesiol. Scand. 39 Suppl. 108 3-14 (1995).
22. 22. R.S. LEEUWIN, A. ZEEGERS, H. VAN WILGENBURG, Eur. J. PharmaCol. 229 149-152 (1996).
23. 23. W. HAEFELY, J.R. MARTIN, P. SCHOCH, TIPS, 11 452-456 (1990).
24. 24. G. RICHARDS, P. SCHOCH, F. JENCK, in: Rodgers R.J., Cooper S.J. (eds.) 5-HT (1A), Agonist 5 HT(3), Antagonist and Benzodiazepines: Their Comparative Behavioural Pharmacology, 1-30 (1991).
25. 25. R. GONZALEZ, A. ZEEGERS, J.J. EIGENHUIS, R.S. LEEUWIN, H. VAN WILGENBURG, Europ. J. Pharmacol. 183 6-7 (1990).
26. 26. M. MESTRE, T. CARRIOT, C. BELIN, A. UZAN, C. RENAULT, M.C. DUBROECQ, C. GUEREMY, G. LE FUR, Life Sci, 35 953-962 (1984).
27. 27. V. SAANO, M. RATY, E. MACDONALD, Pharmacol. Toxicol. 64 147-149 (1989).
28. 28. P.J. MARANGOS, J. PATEL, J.P. BOULENGER, R. CLARK-ROSENBERG, Mol. Pharmacol. 22 26-32 (1982).
29. 29. Y. EDOUTE, J. GIRIS, S.A. BEN-HAIM, A. LOCHNER, A. WEIZMAN, G, HAYAM, Y. KATZ, M. GAVISH, Pharmacology 46 224-230 (1993).
30. 30. M. GAVISH, Y. KATZ, S. BAR-AMI, R. WEIZMAN, J. Neurochem. 58 1589-1601 (1992).
31. 31. M.W. MCENERY, A.M. SNOWMAN, R.R. TRIFILETTI, S.H. SNYDER, Proc. Natl. Acad. Sci. 89 3170-3174 (1992).
32. 32. G. LE FUR, N. VAUCHER, M.L. PERRIER, A. FLAMIER, J. BENAVIDES, C. RENAULT, M.C. DUBROEUCQ, C. GUEREMY, A. UZAN, Life Sci. 33 449-457 (1983).
33. 33. E.R. BARNEA, F. FARES, M. GAVISH, Molec. Cell. Endocr. 64 155-159 (1989).
34. 34. J.F. FRENCH, M.A. MATLIB, FASEB J. (Abstr.) 2 A786 (1988).
35. 35. S.L. ERDO, Trends Pharmacol. Sci. 6 205-208 (1985).
36. 36. W.E. HAEFELY, Europ. J. Anaesthesiol. suppl. 2 25-36 (1988).
37. 37. J. BENAVIDES, D, QUARTERONET, F. IMBAULT, C. MALGOURIS, A. UZAN, C. RENAULT, M. C. DUBROEUCQ, C GUEREMY, G. LE FUR, J. Neurochem. 41 1744 (1983).
38. 38. C. MARESCAUX, G. MICHELETTI, M. VERGUES, A. DEPANTIS, L. RUMBACH, J.M. WARTER, Europ. J. Pharmacol. 102 355-359 (1984).